NEOGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Neogen Corporation and Encourages Investors to Contact the Firm

Core Viewpoint - A class action lawsuit has been filed against Neogen Corporation for allegedly misrepresenting the status of its integration with 3M and failing to disclose the negative impacts on its financial health during the Class Period from January 5, 2023, to June 3, 2025 [1][3]. Financial Performance and Impact - Neogen reported a significant GAAP net income loss in Q2 2025, including a $461 million non-cash goodwill impairment charge related to the 3M acquisition, leading to a 5% decline in stock price to $12.36 per share [4]. - In Q1 2025, Neogen's revenue fell by 3.4% to $221 million due to integration issues, resulting in a 28% drop in stock price to $5.02 per share after cutting FY25 guidance and announcing CEO Adent's resignation [5]. - On June 4, 2025, Neogen projected an EBITDA margin in the high teens, a significant decrease from the previous quarter's 22%, causing an additional 17% drop in stock price to $4.96 per share [6]. Legal Proceedings - Investors who acquired Neogen shares during the Class Period are encouraged to contact Bragar Eagel & Squire, P.C. to discuss their legal rights and options [1][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is September 16, 2025 [1]. Company Background - Neogen Corporation is publicly traded on NASDAQ under the ticker NEOG and has faced scrutiny regarding its financial disclosures and integration processes with 3M [1][3].